nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—Cytochrome P450 3A Inhibitors—Crizotinib—lung cancer	0.345	0.616	CiPCiCtD
Ivacaftor—P-Glycoprotein Inhibitors—Crizotinib—lung cancer	0.215	0.385	CiPCiCtD
Ivacaftor—ALB—lung cancer	0.0773	0.512	CbGaD
Ivacaftor—ABCB1—lung cancer	0.0737	0.488	CbGaD
Ivacaftor—ORM1—Gefitinib—lung cancer	0.0414	0.186	CbGbCtD
Ivacaftor—ORM1—Erlotinib—lung cancer	0.0245	0.11	CbGbCtD
Ivacaftor—ALB—Gefitinib—lung cancer	0.0174	0.0781	CbGbCtD
Ivacaftor—ALB—Erlotinib—lung cancer	0.0103	0.0462	CbGbCtD
Ivacaftor—ABCB1—Topotecan—lung cancer	0.00997	0.0446	CbGbCtD
Ivacaftor—ALB—Irinotecan—lung cancer	0.00931	0.0417	CbGbCtD
Ivacaftor—ABCB1—Gefitinib—lung cancer	0.00912	0.0408	CbGbCtD
Ivacaftor—ABCB1—Vinorelbine—lung cancer	0.00703	0.0315	CbGbCtD
Ivacaftor—CYP3A4—Topotecan—lung cancer	0.00597	0.0268	CbGbCtD
Ivacaftor—ABCB1—Crizotinib—lung cancer	0.00559	0.025	CbGbCtD
Ivacaftor—CYP3A4—Gefitinib—lung cancer	0.00546	0.0245	CbGbCtD
Ivacaftor—ABCB1—Gemcitabine—lung cancer	0.00546	0.0245	CbGbCtD
Ivacaftor—ABCB1—Erlotinib—lung cancer	0.00539	0.0241	CbGbCtD
Ivacaftor—CYP3A4—Teniposide—lung cancer	0.0053	0.0237	CbGbCtD
Ivacaftor—ABCB1—Paclitaxel—lung cancer	0.00494	0.0221	CbGbCtD
Ivacaftor—ALB—Methotrexate—lung cancer	0.00493	0.0221	CbGbCtD
Ivacaftor—ABCB1—Irinotecan—lung cancer	0.00487	0.0218	CbGbCtD
Ivacaftor—ABCB1—Vinblastine—lung cancer	0.00433	0.0194	CbGbCtD
Ivacaftor—CYP3A4—Vinorelbine—lung cancer	0.00421	0.0188	CbGbCtD
Ivacaftor—ABCB1—Cisplatin—lung cancer	0.00397	0.0178	CbGbCtD
Ivacaftor—ABCB1—Etoposide—lung cancer	0.0039	0.0175	CbGbCtD
Ivacaftor—ABCB1—Docetaxel—lung cancer	0.00357	0.016	CbGbCtD
Ivacaftor—CYP3A4—Crizotinib—lung cancer	0.00335	0.015	CbGbCtD
Ivacaftor—CYP3A4—Erlotinib—lung cancer	0.00323	0.0145	CbGbCtD
Ivacaftor—CYP3A4—Paclitaxel—lung cancer	0.00296	0.0132	CbGbCtD
Ivacaftor—CYP3A4—Irinotecan—lung cancer	0.00292	0.0131	CbGbCtD
Ivacaftor—ABCB1—Doxorubicin—lung cancer	0.00266	0.0119	CbGbCtD
Ivacaftor—CYP3A4—Vinblastine—lung cancer	0.00259	0.0116	CbGbCtD
Ivacaftor—ABCB1—Methotrexate—lung cancer	0.00258	0.0115	CbGbCtD
Ivacaftor—CYP3A4—Etoposide—lung cancer	0.00234	0.0105	CbGbCtD
Ivacaftor—CYP3A4—Docetaxel—lung cancer	0.00214	0.00957	CbGbCtD
Ivacaftor—CYP3A4—Doxorubicin—lung cancer	0.00159	0.00714	CbGbCtD
Ivacaftor—CFTR—respiratory system—lung cancer	0.000531	0.163	CbGeAlD
Ivacaftor—CFTR—epithelium—lung cancer	0.000444	0.137	CbGeAlD
Ivacaftor—CFTR—bronchus—lung cancer	0.000437	0.135	CbGeAlD
Ivacaftor—CFTR—trachea—lung cancer	0.000393	0.121	CbGeAlD
Ivacaftor—ALB—mammary gland—lung cancer	0.000355	0.109	CbGeAlD
Ivacaftor—CFTR—lung—lung cancer	0.000282	0.0868	CbGeAlD
Ivacaftor—Abdominal pain—Gefitinib—lung cancer	0.000172	0.00367	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Irinotecan—lung cancer	0.00017	0.00363	CcSEcCtD
Ivacaftor—Nasal congestion—Paclitaxel—lung cancer	0.000169	0.00361	CcSEcCtD
Ivacaftor—Mediastinal disorder—Topotecan—lung cancer	0.000167	0.00356	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Gemcitabine—lung cancer	0.000165	0.00354	CcSEcCtD
Ivacaftor—Mediastinal disorder—Erlotinib—lung cancer	0.000165	0.00352	CcSEcCtD
Ivacaftor—Diarrhoea—Crizotinib—lung cancer	0.000164	0.0035	CcSEcCtD
Ivacaftor—Dizziness—Crizotinib—lung cancer	0.000158	0.00338	CcSEcCtD
Ivacaftor—ORM1—bone marrow—lung cancer	0.000158	0.0486	CbGeAlD
Ivacaftor—Hypoglycaemia—Paclitaxel—lung cancer	0.000158	0.00337	CcSEcCtD
Ivacaftor—Connective tissue disorder—Vinorelbine—lung cancer	0.000155	0.00332	CcSEcCtD
Ivacaftor—Breast disorder—Cisplatin—lung cancer	0.000155	0.00331	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Cisplatin—lung cancer	0.000154	0.0033	CcSEcCtD
Ivacaftor—Nasopharyngitis—Cisplatin—lung cancer	0.000153	0.00327	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Irinotecan—lung cancer	0.000151	0.00324	CcSEcCtD
Ivacaftor—Rash—Crizotinib—lung cancer	0.000151	0.00323	CcSEcCtD
Ivacaftor—Dermatitis—Crizotinib—lung cancer	0.000151	0.00322	CcSEcCtD
Ivacaftor—Diarrhoea—Pemetrexed—lung cancer	0.00015	0.0032	CcSEcCtD
Ivacaftor—Diarrhoea—Gefitinib—lung cancer	0.000149	0.00318	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Teniposide—lung cancer	0.000145	0.0031	CcSEcCtD
Ivacaftor—Dizziness—Pemetrexed—lung cancer	0.000145	0.00309	CcSEcCtD
Ivacaftor—ORM1—lung—lung cancer	0.000143	0.0441	CbGeAlD
Ivacaftor—Hyperaesthesia—Doxorubicin—lung cancer	0.000143	0.00305	CcSEcCtD
Ivacaftor—Mediastinal disorder—Vinorelbine—lung cancer	0.000142	0.00305	CcSEcCtD
Ivacaftor—Nausea—Crizotinib—lung cancer	0.000142	0.00304	CcSEcCtD
Ivacaftor—Abdominal pain—Teniposide—lung cancer	0.00014	0.00299	CcSEcCtD
Ivacaftor—Breast disorder—Paclitaxel—lung cancer	0.000139	0.00297	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Paclitaxel—lung cancer	0.000138	0.00296	CcSEcCtD
Ivacaftor—Rash—Pemetrexed—lung cancer	0.000138	0.00295	CcSEcCtD
Ivacaftor—Dermatitis—Pemetrexed—lung cancer	0.000138	0.00295	CcSEcCtD
Ivacaftor—Nasopharyngitis—Paclitaxel—lung cancer	0.000137	0.00294	CcSEcCtD
Ivacaftor—Rash—Gefitinib—lung cancer	0.000137	0.00293	CcSEcCtD
Ivacaftor—Myalgia—Topotecan—lung cancer	0.000137	0.00293	CcSEcCtD
Ivacaftor—Arthralgia—Topotecan—lung cancer	0.000137	0.00293	CcSEcCtD
Ivacaftor—Dermatitis—Gefitinib—lung cancer	0.000137	0.00293	CcSEcCtD
Ivacaftor—Hepatic enzyme increased—Methotrexate—lung cancer	0.000137	0.00292	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000136	0.00291	CcSEcCtD
Ivacaftor—Myalgia—Erlotinib—lung cancer	0.000136	0.0029	CcSEcCtD
Ivacaftor—Arthralgia—Erlotinib—lung cancer	0.000136	0.0029	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000135	0.00288	CcSEcCtD
Ivacaftor—Rhinitis—Irinotecan—lung cancer	0.000131	0.0028	CcSEcCtD
Ivacaftor—Infection—Topotecan—lung cancer	0.00013	0.00279	CcSEcCtD
Ivacaftor—Nausea—Pemetrexed—lung cancer	0.00013	0.00278	CcSEcCtD
Ivacaftor—Nausea—Gefitinib—lung cancer	0.000129	0.00276	CcSEcCtD
Ivacaftor—Infection—Erlotinib—lung cancer	0.000129	0.00276	CcSEcCtD
Ivacaftor—Nervous system disorder—Topotecan—lung cancer	0.000129	0.00275	CcSEcCtD
Ivacaftor—Connective tissue disorder—Irinotecan—lung cancer	0.000128	0.00274	CcSEcCtD
Ivacaftor—Skin disorder—Topotecan—lung cancer	0.000128	0.00273	CcSEcCtD
Ivacaftor—Nervous system disorder—Erlotinib—lung cancer	0.000127	0.00272	CcSEcCtD
Ivacaftor—Rhinitis—Gemcitabine—lung cancer	0.000127	0.00272	CcSEcCtD
Ivacaftor—Skin disorder—Erlotinib—lung cancer	0.000126	0.0027	CcSEcCtD
Ivacaftor—Connective tissue disorder—Gemcitabine—lung cancer	0.000125	0.00267	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Paclitaxel—lung cancer	0.000123	0.00264	CcSEcCtD
Ivacaftor—Diarrhoea—Teniposide—lung cancer	0.000121	0.00259	CcSEcCtD
Ivacaftor—Infestation NOS—Etoposide—lung cancer	0.000121	0.00258	CcSEcCtD
Ivacaftor—Infestation—Etoposide—lung cancer	0.000121	0.00258	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Topotecan—lung cancer	0.00012	0.00256	CcSEcCtD
Ivacaftor—Infestation NOS—Paclitaxel—lung cancer	0.000118	0.00253	CcSEcCtD
Ivacaftor—Infestation—Paclitaxel—lung cancer	0.000118	0.00253	CcSEcCtD
Ivacaftor—Blood bilirubin increased—Doxorubicin—lung cancer	0.000118	0.00253	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000118	0.00253	CcSEcCtD
Ivacaftor—Breast disorder—Docetaxel—lung cancer	0.000118	0.00252	CcSEcCtD
Ivacaftor—Mediastinal disorder—Irinotecan—lung cancer	0.000118	0.00251	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.000117	0.00251	CcSEcCtD
Ivacaftor—Myalgia—Vinorelbine—lung cancer	0.000117	0.00251	CcSEcCtD
Ivacaftor—Arthralgia—Vinorelbine—lung cancer	0.000117	0.00251	CcSEcCtD
Ivacaftor—Nasopharyngitis—Docetaxel—lung cancer	0.000117	0.00249	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000116	0.00249	CcSEcCtD
Ivacaftor—Connective tissue disorder—Cisplatin—lung cancer	0.000116	0.00249	CcSEcCtD
Ivacaftor—Gynaecomastia—Methotrexate—lung cancer	0.000116	0.00248	CcSEcCtD
Ivacaftor—Mediastinal disorder—Gemcitabine—lung cancer	0.000114	0.00245	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Topotecan—lung cancer	0.000113	0.00242	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Erlotinib—lung cancer	0.000112	0.0024	CcSEcCtD
Ivacaftor—Rash—Teniposide—lung cancer	0.000112	0.00239	CcSEcCtD
Ivacaftor—Dermatitis—Teniposide—lung cancer	0.000112	0.00239	CcSEcCtD
Ivacaftor—Infection—Vinorelbine—lung cancer	0.000112	0.00239	CcSEcCtD
Ivacaftor—Headache—Teniposide—lung cancer	0.000111	0.00237	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Vinblastine—lung cancer	0.000111	0.00236	CcSEcCtD
Ivacaftor—Tinnitus—Cisplatin—lung cancer	0.00011	0.00236	CcSEcCtD
Ivacaftor—Nervous system disorder—Vinorelbine—lung cancer	0.00011	0.00236	CcSEcCtD
Ivacaftor—Skin disorder—Vinorelbine—lung cancer	0.000109	0.00233	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Topotecan—lung cancer	0.000107	0.0023	CcSEcCtD
Ivacaftor—Abdominal pain—Vinblastine—lung cancer	0.000107	0.00228	CcSEcCtD
Ivacaftor—Mediastinal disorder—Cisplatin—lung cancer	0.000107	0.00228	CcSEcCtD
Ivacaftor—Rhinitis—Paclitaxel—lung cancer	0.000107	0.00228	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Erlotinib—lung cancer	0.000106	0.00227	CcSEcCtD
Ivacaftor—Nausea—Teniposide—lung cancer	0.000105	0.00225	CcSEcCtD
Ivacaftor—Connective tissue disorder—Paclitaxel—lung cancer	0.000104	0.00223	CcSEcCtD
Ivacaftor—Abdominal pain—Topotecan—lung cancer	0.000104	0.00222	CcSEcCtD
Ivacaftor—Abdominal pain—Erlotinib—lung cancer	0.000103	0.0022	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000102	0.00219	CcSEcCtD
Ivacaftor—Infestation NOS—Docetaxel—lung cancer	0.0001	0.00215	CcSEcCtD
Ivacaftor—Infestation—Docetaxel—lung cancer	0.0001	0.00215	CcSEcCtD
Ivacaftor—Tinnitus—Paclitaxel—lung cancer	9.91e-05	0.00212	CcSEcCtD
Ivacaftor—ORM1—lymph node—lung cancer	9.79e-05	0.0301	CbGeAlD
Ivacaftor—Mediastinal disorder—Etoposide—lung cancer	9.77e-05	0.00209	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Vinorelbine—lung cancer	9.7e-05	0.00207	CcSEcCtD
Ivacaftor—Mediastinal disorder—Paclitaxel—lung cancer	9.58e-05	0.00205	CcSEcCtD
Ivacaftor—Myalgia—Gemcitabine—lung cancer	9.41e-05	0.00201	CcSEcCtD
Ivacaftor—Arthralgia—Gemcitabine—lung cancer	9.41e-05	0.00201	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	9.35e-05	0.002	CcSEcCtD
Ivacaftor—Diarrhoea—Vinblastine—lung cancer	9.25e-05	0.00198	CcSEcCtD
Ivacaftor—Infection—Irinotecan—lung cancer	9.2e-05	0.00197	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Vinorelbine—lung cancer	9.18e-05	0.00196	CcSEcCtD
Ivacaftor—Nervous system disorder—Irinotecan—lung cancer	9.08e-05	0.00194	CcSEcCtD
Ivacaftor—Rhinitis—Docetaxel—lung cancer	9.04e-05	0.00193	CcSEcCtD
Ivacaftor—Diarrhoea—Topotecan—lung cancer	8.98e-05	0.00192	CcSEcCtD
Ivacaftor—Infection—Gemcitabine—lung cancer	8.96e-05	0.00192	CcSEcCtD
Ivacaftor—Dizziness—Vinblastine—lung cancer	8.94e-05	0.00191	CcSEcCtD
Ivacaftor—Diarrhoea—Erlotinib—lung cancer	8.89e-05	0.0019	CcSEcCtD
Ivacaftor—Abdominal pain—Vinorelbine—lung cancer	8.88e-05	0.0019	CcSEcCtD
Ivacaftor—Connective tissue disorder—Docetaxel—lung cancer	8.86e-05	0.00189	CcSEcCtD
Ivacaftor—Nervous system disorder—Gemcitabine—lung cancer	8.85e-05	0.00189	CcSEcCtD
Ivacaftor—Myalgia—Cisplatin—lung cancer	8.77e-05	0.00188	CcSEcCtD
Ivacaftor—Skin disorder—Gemcitabine—lung cancer	8.76e-05	0.00187	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	8.71e-05	0.00186	CcSEcCtD
Ivacaftor—Dizziness—Topotecan—lung cancer	8.68e-05	0.00186	CcSEcCtD
Ivacaftor—Dizziness—Erlotinib—lung cancer	8.59e-05	0.00184	CcSEcCtD
Ivacaftor—ALB—lymph node—lung cancer	8.59e-05	0.0264	CbGeAlD
Ivacaftor—Breast disorder—Methotrexate—lung cancer	8.49e-05	0.00181	CcSEcCtD
Ivacaftor—Headache—Vinblastine—lung cancer	8.47e-05	0.00181	CcSEcCtD
Ivacaftor—Infection—Cisplatin—lung cancer	8.36e-05	0.00179	CcSEcCtD
Ivacaftor—Hypoglycaemia—Doxorubicin—lung cancer	8.33e-05	0.00178	CcSEcCtD
Ivacaftor—Rash—Topotecan—lung cancer	8.28e-05	0.00177	CcSEcCtD
Ivacaftor—Dermatitis—Topotecan—lung cancer	8.27e-05	0.00177	CcSEcCtD
Ivacaftor—Nervous system disorder—Cisplatin—lung cancer	8.25e-05	0.00176	CcSEcCtD
Ivacaftor—Headache—Topotecan—lung cancer	8.23e-05	0.00176	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Gemcitabine—lung cancer	8.22e-05	0.00176	CcSEcCtD
Ivacaftor—Rash—Erlotinib—lung cancer	8.19e-05	0.00175	CcSEcCtD
Ivacaftor—Dermatitis—Erlotinib—lung cancer	8.18e-05	0.00175	CcSEcCtD
Ivacaftor—Skin disorder—Cisplatin—lung cancer	8.17e-05	0.00175	CcSEcCtD
Ivacaftor—Headache—Erlotinib—lung cancer	8.14e-05	0.00174	CcSEcCtD
Ivacaftor—Mediastinal disorder—Docetaxel—lung cancer	8.12e-05	0.00174	CcSEcCtD
Ivacaftor—Nausea—Vinblastine—lung cancer	8.03e-05	0.00172	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Irinotecan—lung cancer	8e-05	0.00171	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	7.98e-05	0.00171	CcSEcCtD
Ivacaftor—ABCB1—respiratory system—lung cancer	7.97e-05	0.0245	CbGeAlD
Ivacaftor—Arthralgia—Paclitaxel—lung cancer	7.88e-05	0.00169	CcSEcCtD
Ivacaftor—Myalgia—Paclitaxel—lung cancer	7.88e-05	0.00169	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	7.83e-05	0.00167	CcSEcCtD
Ivacaftor—Nausea—Topotecan—lung cancer	7.8e-05	0.00167	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Gemcitabine—lung cancer	7.79e-05	0.00167	CcSEcCtD
Ivacaftor—Nausea—Erlotinib—lung cancer	7.72e-05	0.00165	CcSEcCtD
Ivacaftor—Diarrhoea—Vinorelbine—lung cancer	7.68e-05	0.00164	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Cisplatin—lung cancer	7.66e-05	0.00164	CcSEcCtD
Ivacaftor—Infection—Etoposide—lung cancer	7.65e-05	0.00164	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Irinotecan—lung cancer	7.57e-05	0.00162	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Methotrexate—lung cancer	7.54e-05	0.00161	CcSEcCtD
Ivacaftor—Infection—Paclitaxel—lung cancer	7.51e-05	0.00161	CcSEcCtD
Ivacaftor—Skin disorder—Etoposide—lung cancer	7.48e-05	0.0016	CcSEcCtD
Ivacaftor—Dizziness—Vinorelbine—lung cancer	7.43e-05	0.00159	CcSEcCtD
Ivacaftor—Nervous system disorder—Paclitaxel—lung cancer	7.41e-05	0.00158	CcSEcCtD
Ivacaftor—Breast disorder—Doxorubicin—lung cancer	7.35e-05	0.00157	CcSEcCtD
Ivacaftor—Skin disorder—Paclitaxel—lung cancer	7.34e-05	0.00157	CcSEcCtD
Ivacaftor—Abdominal pain—Irinotecan—lung cancer	7.32e-05	0.00157	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Doxorubicin—lung cancer	7.32e-05	0.00157	CcSEcCtD
Ivacaftor—Nasopharyngitis—Doxorubicin—lung cancer	7.27e-05	0.00155	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Cisplatin—lung cancer	7.26e-05	0.00155	CcSEcCtD
Ivacaftor—Infestation—Methotrexate—lung cancer	7.24e-05	0.00155	CcSEcCtD
Ivacaftor—Infestation NOS—Methotrexate—lung cancer	7.24e-05	0.00155	CcSEcCtD
Ivacaftor—Rash—Vinorelbine—lung cancer	7.08e-05	0.00151	CcSEcCtD
Ivacaftor—Dermatitis—Vinorelbine—lung cancer	7.08e-05	0.00151	CcSEcCtD
Ivacaftor—Headache—Vinorelbine—lung cancer	7.04e-05	0.0015	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Paclitaxel—lung cancer	6.88e-05	0.00147	CcSEcCtD
Ivacaftor—Arthralgia—Docetaxel—lung cancer	6.68e-05	0.00143	CcSEcCtD
Ivacaftor—Myalgia—Docetaxel—lung cancer	6.68e-05	0.00143	CcSEcCtD
Ivacaftor—Nausea—Vinorelbine—lung cancer	6.67e-05	0.00143	CcSEcCtD
Ivacaftor—ABCB1—epithelium—lung cancer	6.66e-05	0.0205	CbGeAlD
Ivacaftor—Gastrointestinal disorder—Etoposide—lung cancer	6.65e-05	0.00142	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	6.63e-05	0.00142	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Doxorubicin—lung cancer	6.53e-05	0.0014	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Paclitaxel—lung cancer	6.52e-05	0.00139	CcSEcCtD
Ivacaftor—Infection—Docetaxel—lung cancer	6.36e-05	0.00136	CcSEcCtD
Ivacaftor—Diarrhoea—Irinotecan—lung cancer	6.34e-05	0.00136	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Etoposide—lung cancer	6.3e-05	0.00135	CcSEcCtD
Ivacaftor—Nervous system disorder—Docetaxel—lung cancer	6.28e-05	0.00134	CcSEcCtD
Ivacaftor—Infestation NOS—Doxorubicin—lung cancer	6.27e-05	0.00134	CcSEcCtD
Ivacaftor—Infestation—Doxorubicin—lung cancer	6.27e-05	0.00134	CcSEcCtD
Ivacaftor—Skin disorder—Docetaxel—lung cancer	6.22e-05	0.00133	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Paclitaxel—lung cancer	6.18e-05	0.00132	CcSEcCtD
Ivacaftor—Diarrhoea—Gemcitabine—lung cancer	6.17e-05	0.00132	CcSEcCtD
Ivacaftor—Dizziness—Irinotecan—lung cancer	6.13e-05	0.00131	CcSEcCtD
Ivacaftor—Abdominal pain—Etoposide—lung cancer	6.09e-05	0.0013	CcSEcCtD
Ivacaftor—Tinnitus—Methotrexate—lung cancer	6.06e-05	0.0013	CcSEcCtD
Ivacaftor—Abdominal pain—Paclitaxel—lung cancer	5.97e-05	0.00128	CcSEcCtD
Ivacaftor—ABCB1—trachea—lung cancer	5.89e-05	0.0181	CbGeAlD
Ivacaftor—Mediastinal disorder—Methotrexate—lung cancer	5.85e-05	0.00125	CcSEcCtD
Ivacaftor—Rash—Irinotecan—lung cancer	5.84e-05	0.00125	CcSEcCtD
Ivacaftor—Dermatitis—Irinotecan—lung cancer	5.84e-05	0.00125	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Docetaxel—lung cancer	5.83e-05	0.00125	CcSEcCtD
Ivacaftor—Headache—Irinotecan—lung cancer	5.8e-05	0.00124	CcSEcCtD
Ivacaftor—Diarrhoea—Cisplatin—lung cancer	5.75e-05	0.00123	CcSEcCtD
Ivacaftor—Rash—Gemcitabine—lung cancer	5.69e-05	0.00122	CcSEcCtD
Ivacaftor—Dermatitis—Gemcitabine—lung cancer	5.68e-05	0.00122	CcSEcCtD
Ivacaftor—Headache—Gemcitabine—lung cancer	5.65e-05	0.00121	CcSEcCtD
Ivacaftor—Rhinitis—Doxorubicin—lung cancer	5.64e-05	0.00121	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Docetaxel—lung cancer	5.53e-05	0.00118	CcSEcCtD
Ivacaftor—Connective tissue disorder—Doxorubicin—lung cancer	5.53e-05	0.00118	CcSEcCtD
Ivacaftor—Nausea—Irinotecan—lung cancer	5.5e-05	0.00118	CcSEcCtD
Ivacaftor—Nausea—Gemcitabine—lung cancer	5.36e-05	0.00115	CcSEcCtD
Ivacaftor—Rash—Cisplatin—lung cancer	5.3e-05	0.00113	CcSEcCtD
Ivacaftor—Dermatitis—Cisplatin—lung cancer	5.3e-05	0.00113	CcSEcCtD
Ivacaftor—Diarrhoea—Etoposide—lung cancer	5.27e-05	0.00113	CcSEcCtD
Ivacaftor—Tinnitus—Doxorubicin—lung cancer	5.24e-05	0.00112	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Docetaxel—lung cancer	5.24e-05	0.00112	CcSEcCtD
Ivacaftor—Diarrhoea—Paclitaxel—lung cancer	5.17e-05	0.00111	CcSEcCtD
Ivacaftor—Dizziness—Etoposide—lung cancer	5.1e-05	0.00109	CcSEcCtD
Ivacaftor—Mediastinal disorder—Doxorubicin—lung cancer	5.07e-05	0.00108	CcSEcCtD
Ivacaftor—Abdominal pain—Docetaxel—lung cancer	5.06e-05	0.00108	CcSEcCtD
Ivacaftor—Dizziness—Paclitaxel—lung cancer	5e-05	0.00107	CcSEcCtD
Ivacaftor—Nausea—Cisplatin—lung cancer	5e-05	0.00107	CcSEcCtD
Ivacaftor—Rash—Etoposide—lung cancer	4.86e-05	0.00104	CcSEcCtD
Ivacaftor—Dermatitis—Etoposide—lung cancer	4.85e-05	0.00104	CcSEcCtD
Ivacaftor—Headache—Etoposide—lung cancer	4.83e-05	0.00103	CcSEcCtD
Ivacaftor—Myalgia—Methotrexate—lung cancer	4.81e-05	0.00103	CcSEcCtD
Ivacaftor—Arthralgia—Methotrexate—lung cancer	4.81e-05	0.00103	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.78e-05	0.00102	CcSEcCtD
Ivacaftor—Rash—Paclitaxel—lung cancer	4.76e-05	0.00102	CcSEcCtD
Ivacaftor—Dermatitis—Paclitaxel—lung cancer	4.76e-05	0.00102	CcSEcCtD
Ivacaftor—Headache—Paclitaxel—lung cancer	4.73e-05	0.00101	CcSEcCtD
Ivacaftor—ABCB1—bone marrow—lung cancer	4.67e-05	0.0144	CbGeAlD
Ivacaftor—Infection—Methotrexate—lung cancer	4.59e-05	0.000981	CcSEcCtD
Ivacaftor—Nausea—Etoposide—lung cancer	4.58e-05	0.000979	CcSEcCtD
Ivacaftor—Nervous system disorder—Methotrexate—lung cancer	4.53e-05	0.000968	CcSEcCtD
Ivacaftor—Nausea—Paclitaxel—lung cancer	4.49e-05	0.00096	CcSEcCtD
Ivacaftor—Skin disorder—Methotrexate—lung cancer	4.48e-05	0.000959	CcSEcCtD
Ivacaftor—Diarrhoea—Docetaxel—lung cancer	4.38e-05	0.000937	CcSEcCtD
Ivacaftor—Dizziness—Docetaxel—lung cancer	4.23e-05	0.000906	CcSEcCtD
Ivacaftor—ABCB1—lung—lung cancer	4.23e-05	0.013	CbGeAlD
Ivacaftor—Musculoskeletal discomfort—Methotrexate—lung cancer	4.2e-05	0.000899	CcSEcCtD
Ivacaftor—Arthralgia—Doxorubicin—lung cancer	4.17e-05	0.000892	CcSEcCtD
Ivacaftor—Myalgia—Doxorubicin—lung cancer	4.17e-05	0.000892	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.14e-05	0.000885	CcSEcCtD
Ivacaftor—Rash—Docetaxel—lung cancer	4.04e-05	0.000863	CcSEcCtD
Ivacaftor—Dermatitis—Docetaxel—lung cancer	4.03e-05	0.000863	CcSEcCtD
Ivacaftor—Headache—Docetaxel—lung cancer	4.01e-05	0.000858	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Methotrexate—lung cancer	3.98e-05	0.000852	CcSEcCtD
Ivacaftor—Infection—Doxorubicin—lung cancer	3.97e-05	0.000849	CcSEcCtD
Ivacaftor—Nervous system disorder—Doxorubicin—lung cancer	3.92e-05	0.000838	CcSEcCtD
Ivacaftor—Skin disorder—Doxorubicin—lung cancer	3.88e-05	0.00083	CcSEcCtD
Ivacaftor—Nausea—Docetaxel—lung cancer	3.8e-05	0.000813	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Methotrexate—lung cancer	3.77e-05	0.000807	CcSEcCtD
Ivacaftor—Abdominal pain—Methotrexate—lung cancer	3.65e-05	0.00078	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.64e-05	0.000779	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Doxorubicin—lung cancer	3.45e-05	0.000738	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Doxorubicin—lung cancer	3.27e-05	0.000699	CcSEcCtD
Ivacaftor—Abdominal pain—Doxorubicin—lung cancer	3.16e-05	0.000676	CcSEcCtD
Ivacaftor—Diarrhoea—Methotrexate—lung cancer	3.16e-05	0.000675	CcSEcCtD
Ivacaftor—Dizziness—Methotrexate—lung cancer	3.05e-05	0.000653	CcSEcCtD
Ivacaftor—Rash—Methotrexate—lung cancer	2.91e-05	0.000622	CcSEcCtD
Ivacaftor—Dermatitis—Methotrexate—lung cancer	2.91e-05	0.000622	CcSEcCtD
Ivacaftor—ABCB1—lymph node—lung cancer	2.89e-05	0.0089	CbGeAlD
Ivacaftor—Headache—Methotrexate—lung cancer	2.89e-05	0.000618	CcSEcCtD
Ivacaftor—Nausea—Methotrexate—lung cancer	2.74e-05	0.000586	CcSEcCtD
Ivacaftor—Diarrhoea—Doxorubicin—lung cancer	2.73e-05	0.000585	CcSEcCtD
Ivacaftor—Dizziness—Doxorubicin—lung cancer	2.64e-05	0.000565	CcSEcCtD
Ivacaftor—Rash—Doxorubicin—lung cancer	2.52e-05	0.000539	CcSEcCtD
Ivacaftor—Dermatitis—Doxorubicin—lung cancer	2.52e-05	0.000538	CcSEcCtD
Ivacaftor—Headache—Doxorubicin—lung cancer	2.5e-05	0.000535	CcSEcCtD
Ivacaftor—Nausea—Doxorubicin—lung cancer	2.37e-05	0.000508	CcSEcCtD
Ivacaftor—ABCB1—Metabolism—ATP5H—lung cancer	1.01e-05	0.000642	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	9.92e-06	0.000628	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ADCY1—lung cancer	9.84e-06	0.000623	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ABCG2—lung cancer	9.84e-06	0.000623	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—EGF—lung cancer	9.81e-06	0.000621	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	9.77e-06	0.000619	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	9.66e-06	0.000611	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—GSTP1—lung cancer	9.59e-06	0.000607	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	9.59e-06	0.000607	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	9.46e-06	0.000599	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HSD17B10—lung cancer	9.44e-06	0.000598	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—APP—lung cancer	9.42e-06	0.000596	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—TF—lung cancer	9.15e-06	0.000579	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	9.1e-06	0.000576	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	9.06e-06	0.000574	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PLBD1—lung cancer	9.04e-06	0.000572	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—GSTM1—lung cancer	8.81e-06	0.000558	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CKB—lung cancer	8.77e-06	0.000556	CbGpPWpGaD
Ivacaftor—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	8.72e-06	0.000552	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	8.72e-06	0.000552	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	8.69e-06	0.00055	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	8.64e-06	0.000547	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	8.62e-06	0.000546	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	8.62e-06	0.000546	CbGpPWpGaD
Ivacaftor—ALB—Selenium Micronutrient Network—IL6—lung cancer	8.57e-06	0.000543	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—CYP1A1—lung cancer	8.36e-06	0.000529	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HSD17B10—lung cancer	8.27e-06	0.000524	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTM2—lung cancer	8.25e-06	0.000522	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CNDP2—lung cancer	8.25e-06	0.000522	CbGpPWpGaD
Ivacaftor—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	8.24e-06	0.000522	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—MTMR3—lung cancer	8.02e-06	0.000508	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	8.01e-06	0.000508	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PGAM1—lung cancer	7.82e-06	0.000495	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	7.79e-06	0.000493	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	7.69e-06	0.000487	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CKB—lung cancer	7.69e-06	0.000487	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	7.67e-06	0.000485	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	7.6e-06	0.000481	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	7.58e-06	0.00048	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—ITGB1—lung cancer	7.53e-06	0.000477	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2A7—lung cancer	7.46e-06	0.000472	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	7.42e-06	0.00047	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AZIN2—lung cancer	7.35e-06	0.000465	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—COL4A3BP—lung cancer	7.35e-06	0.000465	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—SDC4—lung cancer	7.3e-06	0.000462	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTM2—lung cancer	7.23e-06	0.000458	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CNDP2—lung cancer	7.23e-06	0.000458	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—MTMR3—lung cancer	7.03e-06	0.000445	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	6.98e-06	0.000442	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	6.88e-06	0.000436	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PGAM1—lung cancer	6.85e-06	0.000434	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	6.7e-06	0.000424	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	6.69e-06	0.000423	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—RRM1—lung cancer	6.65e-06	0.000421	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTA3—lung cancer	6.65e-06	0.000421	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2A7—lung cancer	6.54e-06	0.000414	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	6.48e-06	0.000411	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	6.47e-06	0.00041	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—SDC4—lung cancer	6.4e-06	0.000405	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—AVP—lung cancer	6.34e-06	0.000402	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—B4GALT5—lung cancer	6.25e-06	0.000396	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ATP5H—lung cancer	6.25e-06	0.000396	CbGpPWpGaD
Ivacaftor—CYP3A4—Biological oxidations—POMC—lung cancer	6.23e-06	0.000394	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	6.17e-06	0.000391	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	6.14e-06	0.000389	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	6.09e-06	0.000386	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTA4—lung cancer	6.08e-06	0.000385	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6e-06	0.00038	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.94e-06	0.000376	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	5.93e-06	0.000376	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTA2—lung cancer	5.93e-06	0.000375	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MMP1—lung cancer	5.86e-06	0.000371	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	5.84e-06	0.00037	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—RRM1—lung cancer	5.83e-06	0.000369	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA3—lung cancer	5.83e-06	0.000369	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTA1—lung cancer	5.72e-06	0.000362	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCC3—lung cancer	5.65e-06	0.000358	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	5.61e-06	0.000355	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—APOA1—lung cancer	5.6e-06	0.000355	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PLBD1—lung cancer	5.57e-06	0.000353	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	5.56e-06	0.000352	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	5.53e-06	0.00035	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—B4GALT5—lung cancer	5.48e-06	0.000347	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AKR1C1—lung cancer	5.48e-06	0.000347	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	5.37e-06	0.00034	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA4—lung cancer	5.33e-06	0.000337	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—UGT1A1—lung cancer	5.32e-06	0.000337	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.26e-06	0.000333	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA2—lung cancer	5.19e-06	0.000329	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GNG11—lung cancer	5.13e-06	0.000325	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CG—lung cancer	5.11e-06	0.000324	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.1e-06	0.000323	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HSD17B10—lung cancer	5.09e-06	0.000323	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—EGF—lung cancer	5.05e-06	0.00032	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTA1—lung cancer	5.01e-06	0.000317	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	4.97e-06	0.000315	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCC3—lung cancer	4.95e-06	0.000314	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ALDOA—lung cancer	4.88e-06	0.000309	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	4.85e-06	0.000307	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AKR1C1—lung cancer	4.8e-06	0.000304	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—CREBBP—lung cancer	4.74e-06	0.0003	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NCOA3—lung cancer	4.74e-06	0.0003	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CKB—lung cancer	4.74e-06	0.0003	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—UGT1A1—lung cancer	4.66e-06	0.000295	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.66e-06	0.000295	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	4.63e-06	0.000293	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCG2—lung cancer	4.61e-06	0.000292	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ADCY1—lung cancer	4.61e-06	0.000292	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.56e-06	0.000289	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ENO2—lung cancer	4.52e-06	0.000286	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—HPGDS—lung cancer	4.52e-06	0.000286	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CD—lung cancer	4.5e-06	0.000285	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PPP2R1B—lung cancer	4.49e-06	0.000284	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GNG11—lung cancer	4.49e-06	0.000284	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTM2—lung cancer	4.45e-06	0.000282	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CNDP2—lung cancer	4.45e-06	0.000282	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.43e-06	0.000281	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.41e-06	0.00028	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTT1—lung cancer	4.38e-06	0.000278	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GCLC—lung cancer	4.33e-06	0.000274	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2A6—lung cancer	4.33e-06	0.000274	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—MTMR3—lung cancer	4.33e-06	0.000274	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.32e-06	0.000273	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ALDOA—lung cancer	4.28e-06	0.000271	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	4.25e-06	0.000269	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PGAM1—lung cancer	4.22e-06	0.000267	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NCOA3—lung cancer	4.15e-06	0.000263	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ENO1—lung cancer	4.11e-06	0.00026	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	4.1e-06	0.00026	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.09e-06	0.000259	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ADCY1—lung cancer	4.04e-06	0.000256	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ABCG2—lung cancer	4.04e-06	0.000256	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2A7—lung cancer	4.03e-06	0.000255	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—RAF1—lung cancer	4.01e-06	0.000254	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ENO2—lung cancer	3.96e-06	0.000251	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—HPGDS—lung cancer	3.96e-06	0.000251	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—SDC4—lung cancer	3.94e-06	0.00025	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PPP2R1B—lung cancer	3.94e-06	0.000249	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CB—lung cancer	3.92e-06	0.000248	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTT1—lung cancer	3.84e-06	0.000243	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2A6—lung cancer	3.8e-06	0.00024	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GCLC—lung cancer	3.8e-06	0.00024	CbGpPWpGaD
Ivacaftor—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	3.79e-06	0.00024	CbGpPWpGaD
Ivacaftor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.73e-06	0.000236	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP2E1—lung cancer	3.68e-06	0.000233	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—NQO1—lung cancer	3.64e-06	0.000231	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ENO1—lung cancer	3.6e-06	0.000228	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—IL2—lung cancer	3.6e-06	0.000228	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.6e-06	0.000228	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—RRM1—lung cancer	3.59e-06	0.000227	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA3—lung cancer	3.59e-06	0.000227	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.57e-06	0.000226	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.53e-06	0.000224	CbGpPWpGaD
Ivacaftor—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	3.47e-06	0.00022	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—B4GALT5—lung cancer	3.37e-06	0.000214	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	3.37e-06	0.000213	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—STK11—lung cancer	3.28e-06	0.000208	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA4—lung cancer	3.28e-06	0.000208	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—EP300—lung cancer	3.23e-06	0.000204	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP2E1—lung cancer	3.23e-06	0.000204	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA2—lung cancer	3.2e-06	0.000203	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—NQO1—lung cancer	3.19e-06	0.000202	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—SRC—lung cancer	3.14e-06	0.000199	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTA1—lung cancer	3.09e-06	0.000195	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.08e-06	0.000195	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—VEGFA—lung cancer	3.06e-06	0.000194	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCC3—lung cancer	3.05e-06	0.000193	CbGpPWpGaD
Ivacaftor—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.04e-06	0.000193	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTP1—lung cancer	3.04e-06	0.000192	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—NRAS—lung cancer	3.02e-06	0.000191	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CAT—lung cancer	2.96e-06	0.000187	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AKR1C1—lung cancer	2.96e-06	0.000187	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.94e-06	0.000186	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—MAPK3—lung cancer	2.89e-06	0.000183	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—STK11—lung cancer	2.88e-06	0.000182	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ABCB1—lung cancer	2.88e-06	0.000182	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—UGT1A1—lung cancer	2.87e-06	0.000182	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—TYMS—lung cancer	2.82e-06	0.000179	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—GSTM1—lung cancer	2.79e-06	0.000177	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GNG11—lung cancer	2.77e-06	0.000175	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTP1—lung cancer	2.66e-06	0.000169	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CYP1A1—lung cancer	2.65e-06	0.000168	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ALDOA—lung cancer	2.63e-06	0.000167	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—ERCC2—lung cancer	2.63e-06	0.000166	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—KRAS—lung cancer	2.6e-06	0.000165	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CAT—lung cancer	2.59e-06	0.000164	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NCOA3—lung cancer	2.56e-06	0.000162	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ADCY1—lung cancer	2.49e-06	0.000158	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCG2—lung cancer	2.49e-06	0.000158	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—TYMS—lung cancer	2.47e-06	0.000157	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—GSTM1—lung cancer	2.45e-06	0.000155	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ENO2—lung cancer	2.44e-06	0.000154	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—HPGDS—lung cancer	2.44e-06	0.000154	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.42e-06	0.000154	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—PIK3CA—lung cancer	2.39e-06	0.000151	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTT1—lung cancer	2.37e-06	0.00015	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2A6—lung cancer	2.34e-06	0.000148	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GCLC—lung cancer	2.34e-06	0.000148	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CYP1A1—lung cancer	2.32e-06	0.000147	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—TP53—lung cancer	2.31e-06	0.000146	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ERCC2—lung cancer	2.3e-06	0.000146	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—APOA1—lung cancer	2.27e-06	0.000144	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ENO1—lung cancer	2.22e-06	0.00014	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—HRAS—lung cancer	2.21e-06	0.00014	CbGpPWpGaD
Ivacaftor—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.17e-06	0.000138	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CG—lung cancer	2.07e-06	0.000131	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—APOA1—lung cancer	1.99e-06	0.000126	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP2E1—lung cancer	1.99e-06	0.000126	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—POMC—lung cancer	1.97e-06	0.000125	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—NQO1—lung cancer	1.97e-06	0.000125	CbGpPWpGaD
Ivacaftor—ALB—Hemostasis—AKT1—lung cancer	1.95e-06	0.000124	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—CREBBP—lung cancer	1.92e-06	0.000122	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CD—lung cancer	1.82e-06	0.000115	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CG—lung cancer	1.82e-06	0.000115	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—STK11—lung cancer	1.77e-06	0.000112	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—POMC—lung cancer	1.73e-06	0.00011	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—CREBBP—lung cancer	1.68e-06	0.000107	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTP1—lung cancer	1.64e-06	0.000104	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CD—lung cancer	1.6e-06	0.000101	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CAT—lung cancer	1.6e-06	0.000101	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CB—lung cancer	1.59e-06	0.000101	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—ALB—lung cancer	1.58e-06	9.98e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTGS2—lung cancer	1.57e-06	9.97e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ABCB1—lung cancer	1.55e-06	9.83e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—TYMS—lung cancer	1.52e-06	9.66e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—GSTM1—lung cancer	1.51e-06	9.54e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CYP1A1—lung cancer	1.43e-06	9.05e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ERCC2—lung cancer	1.42e-06	8.97e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CB—lung cancer	1.39e-06	8.81e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTGS2—lung cancer	1.38e-06	8.73e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PTEN—lung cancer	1.37e-06	8.69e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—EP300—lung cancer	1.31e-06	8.29e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—APOA1—lung cancer	1.23e-06	7.76e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PTEN—lung cancer	1.2e-06	7.62e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—EP300—lung cancer	1.15e-06	7.26e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CG—lung cancer	1.12e-06	7.09e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—POMC—lung cancer	1.07e-06	6.75e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—CREBBP—lung cancer	1.04e-06	6.57e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CD—lung cancer	9.84e-07	6.23e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—ALB—lung cancer	9.71e-07	6.15e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—PIK3CA—lung cancer	9.68e-07	6.13e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CB—lung cancer	8.58e-07	5.43e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTGS2—lung cancer	8.5e-07	5.38e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—PIK3CA—lung cancer	8.49e-07	5.37e-05	CbGpPWpGaD
Ivacaftor—ALB—Metabolism—AKT1—lung cancer	7.91e-07	5.01e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PTEN—lung cancer	7.41e-07	4.69e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—EP300—lung cancer	7.07e-07	4.48e-05	CbGpPWpGaD
Ivacaftor—ABCB1—Metabolism—AKT1—lung cancer	6.93e-07	4.39e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—PIK3CA—lung cancer	5.23e-07	3.31e-05	CbGpPWpGaD
Ivacaftor—CYP3A4—Metabolism—AKT1—lung cancer	4.27e-07	2.7e-05	CbGpPWpGaD
